Cryptogenic hemoptysis may be a life-threatening condition. Nonsurgical approaches provide immediate control of bleeding in most patients with cryptogenic hemoptysis, with few recurrences in both short and long terms. Dieulafoy disease of the bronchus, unsuspected after routine imaging investigations, may be involved in a subset of patients yet to be determined.
Hemoptysis refers to a wide clinical spectrum, ranging from a nonalarming bloody expectoration to a life-threatening condition associated with an immediate risk of airway obstruction and death. The challenge for the physician caring for patients with hemoptysis is to assess the severity and to identify the underlying cause of bleeding, which may influence both management and outcome. The diagnosis of hemoptysis is usually based on the combination of physical examination, chest X-ray, fiberoptic bronchoscopy, and computed tomography (CT) scan. Despite the currently available diagnostic tools, some 7 to 25% cases of hemoptysis remain without identified etiology (i.e., "cryptogenic" hemoptysis), whatever the severity of the bleeding (1) (2) (3) (4) (5) (6) . Recently, Herth and colleagues (2) reported a substantial inci-(Received in original form September 25, 2006 ; accepted in final form February 28, 2007 ) Correspondence and requests for reprints should be addressed to Muriel Fartoukh, M.D., Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, 4 rue de la Chine, 75020 Paris, France. E-mail: muriel.fartoukh@tnn.aphp.fr 
AT A GLANCE COMMENTARY Scientific Knowledge on the Subject
There is a scarcity of available information on optimal management and outcome of cryptogenic hemoptysis.
What This Study Adds to the Field
Bleeding was controlled in most patients using a routine approach (endoscopy and bronchial artery embolization). Dieulafoy disease of the bronchus may be involved in a subset of patients.
dence of bronchial carcinoma complicating the course of cryptogenic hemoptysis, whereas older studies performed before the era of CT scanning suggested a favorable outcome (7) (8) (9) .
The aims of our study were to describe the clinical spectrum, the management, and both the short-and long-term outcome of a large cohort of consecutive patients diagnosed with cryptogenic hemoptysis, after history, physical exam, chest X-ray, fiberoptic bronchoscopy, and CT scan had excluded any specific lesion of the lung parenchyma that could have been identified as the source of bleeding. The study was conducted in accordance with French law, which does not require approval of an institutional review board or the consent of patients for such retrospective analysis of medical records.
METHODS

Selection of Patients
The study was conducted between December 1995 and August 2004 in Tenon hospital, a tertiary university hospital and referral center for hemoptysis. All consecutive patients admitted to the respiratory intermediate care ward and intensive care unit (6 and 10 beds, respectively) for hemoptysis were prospectively screened. Definite causes of hemoptysis were bronchiectasis, tuberculosis (active and sequels), cancer, and mycetoma; probable causes were pulmonary embolism, infectious pneumonia, and emphysema. Only patients diagnosed with cryptogenic hemoptysis were considered in this study. Patients with recurrent hemoptysis were included in the first episode. A fiberoptic bronchoscopy was performed in all patients within the first 24 hours of admission to assess the presence and location of bronchial blood, active bleeding, and clot. To exclude any specific anatomic lesion as the source of bleeding, chest X-rays and CT scans were reviewed by a radiologist (A.K.) unaware of the patients' clinical condition. Alveolar infiltrate(s) on chest X-ray were considered as abnormalities locating the bleeding. Although all patients had a CT scan performed, only 60 were available for review by the radiologist and were analyzed, considering ground-glass, alveolar, and nodular opacities to be reflections of the filling of the alveolar lumen with blood.
Management of Hemoptysis
All patients received conservative management. The treatments associated with an increased risk of bleeding (aspirin, n ϭ 14; coumadin, n ϭ 5) were stopped, whenever possible. The patients were maintained on strict bed rest and received oxygen to obtain a saturation of 90% or greater. No attempt was made to suppress cough. Antibiotics were prescribed in patients with suspected bacterial pneumonia. Terlipressin was administered intravenously in a few patients (n ϭ 11), mostly before admission to our unit. Bronchial arteriography was first attempted in 50 patients (62%). All the procedures of bronchial artery embolization (BAE) were retrospectively analyzed by our radiologist. A failure of bronchial arteriography was defined as follows: lack of evidence of bronchial or nonbronchial systemic hypervascularization, inability to canulate the vessel, instability of the catheter tip, or visualization of the anterior spinal branch. After surgery, one pathologist (M.A.) performed the pathologic examination of the pulmonary resection.
Analysis of Outcome
Immediate control of bleeding, recurrences, and short-and long-term results of management were analyzed. Immediate control of bleeding was defined as a complete cessation of bleeding during hospital stay after the initial therapeutic approach used (i.e., conservative measures, BAE, or surgery). The follow-up was conducted during a patient visit to our institution or by direct phone contact with the patient after discharge. Complete clinical information was obtained for 73 patients (90%) with follow-up until June 2006.
Statistical Analysis
The patients' demographics and clinical variables were analyzed using common descriptive statistics. Results were expressed as mean (Ϯ SD) and range, unless otherwise stated. Between-group comparisons used Student's t test for categorical variables and the chi-square test for nominal variables. A p value below 0.05 was considered statistically significant. The cumulative control rate of hemoptysis was calculated by the Kaplan-Meier method.
RESULTS
Demographic and Clinical Presentation on Admission
During the study period, 84 of 653 patients (13%) referred to our institution for hemoptysis were diagnosed as having cryptogenic hemoptysis, and 3 of them were secondarily excluded because of missing information. The remaining 81 patients (69 males) were aged 47.9 (Ϯ 12.3) years. The time from bleeding onset to hospitalization or referral to our unit was 1.75 days (Ϯ 3 d; median, 1 d) and 2.7 days (Ϯ 4.2 d; median, 1.5 d), respectively. A smoking history was recorded for 64 patients (79%), 54 of whom were former smokers ( Table 1 ). The cumulative volume of blood was 190 (Ϯ 195) ml on admission (range, 10 to Ͼ 1,000 ml; median, 100 ml) ( Figure 1 ).
Chest X-ray, Fiberoptic Bronchoscopy, and CT Scan
A total of 16 patients (20%) had a single lobar alveolar infiltrate on chest X-ray. The fiberoptic bronchoscopy showed bronchial blood in 75 patients (93%), 32 of whom had localized active bleeding. The CT scan evidenced ground-glass opacities in most patients (n ϭ 47; 78%). A repeated CT scan was performed several months later in 29 patients, demonstrating a complete resolution of the initial abnormalities related to the bleeding.
Management
Conservative measures were used alone in 31 patients (38%) having mild to moderate initial cumulative volume of hemoptysis (65 Ϯ 30 ml; range, 20-150 ml). Conversely, a bronchial arteriography was first attempted in the remaining 50 patients (62%), in whom the volume averaged 270 (Ϯ 210) ml (range, 30 to Ͼ 1,000 ml). The procedure was eventually completed in 43 of these 50 patients, with 6 receiving several embolizations. In all completed BAEs, the bronchial arteries were found to be abnormal, with arterial enlargement (n ϭ 43), localized hypervascularity (n ϭ 32), systemic to pulmonary shunting (n ϭ 4), or contrast † A comorbid condition was present in 38 patients (47%), 11 of whom had several comorbid conditions. ‡ Six patients had a previous lung disease: history of tuberculosis (n ϭ 2), history of pleural disease (n ϭ 2), history of pulmonary venous thromboembolism disease (n ϭ 1), and history of whooping cough (n ϭ 1).
§ Liver cirrhosis was postalcoholic (n ϭ 3) or postviral (n ϭ 3). || Chronic renal insufficiency was related to nephroangiosclerosis (n ϭ 3), IgA nephropathy (n ϭ 1), hepatorenal syndrome (n ϭ 1), and diabetic nephropathy (n ϭ 1).
extravasation into the bronchial lumen (n ϭ 4). There was no case of nonbronchial systemic hypervascularity. An inability to canulate the bronchial artery and the visualization of an anterior spinal branch occurred in seven patients, four of whom underwent surgery; the three remaining patients were managed conservatively, with a subsequent favorable course. Hemoptysis was not controlled in four patients, despite initially having completed BAE; two of these patients underwent surgery (Figure 2) .
Overall, the initial therapeutic approach based on conservative measures alone or completed BAE led to an immediate control of bleeding and to hospital discharge in 31 of 31 (100%) and 39 of 43 (91%) patients, respectively. The mean hospital length of stay of patients initially managed conservatively or receiving BAE differed significantly (3 Ϯ 1.5 vs. 6.2 Ϯ 4.9 d; p Ͻ 0.001).
Surgery
Surgery was performed during hospitalization because of a failure of the attempted bronchial arteriography and persistence of hemoptysis (n ϭ 4) or an uncontrolled bleeding despite a completed BAE (n ϭ 2); three other patients underwent surgery after discharge (recurrence after a completed BAE, n ϭ 2; secondary procedure scheduled after a successfully completed BAE, n ϭ 1). Pathologic examination could thus be performed in nine patients. In five of these, the major finding was the presence of a superficial ectopic artery, which was contiguous to the mucosal epithelium, with a disruption in the bronchial lumen in three, corresponding to Dieulafoy disease of the bronchus (Figure 3 ). Various nonspecific pathologic findings, including hypervascularization, venous dilatation, and hemorrhagic alveolitis, were noted in the four other patients.
Follow-up
Follow-up data were available for 73 patients (90%), for a mean duration of 47.3 (Ϯ 35) months (range, 0.4-133 mo) after initial referral. No lung cancer developed. There were 10 episodes of recurrence of bleeding, which occurred mostly after 1 month (median, 20 mo) ( Table 2) . Hemoptysis recurred at a similar rate in patients managed conservatively and in those in whom the initial BAE was completed (n ϭ 6/34 vs. 3/43; p ϭ 0.17). The overall cumulative rate of control of bleeding without recurrence was 98.5% at 1 month, 93.6% at 1 year, and 86.3% at both 2 and 4 years.
DISCUSSION
Our study aimed at characterizing the clinical spectrum and the course of cryptogenic hemoptysis observed at a single referral center over a 9-year period. One-third of our patients had a cumulative volume greater than 200 ml on admission, emphasizing that cryptogenic hemoptysis may be life-threatening. The first-line management was similar to that currently proposed in hemoptysis associated with a specific cause, favoring conservative measures and interventional radiology over emergency surgery. There were relatively few episodes of recurrence. Surgery was mainly performed in cases of failure of initial BAE and recurrences; unexpectedly, a specific bronchial vascular involvement (Dieulafoy disease) was frequently evidenced on pathologic examination.
Recent studies focusing on hemoptysis of various severities have reported a 7 to 25% incidence rate of cryptogenic hemoptysis, even with the use of CT scan (1-5, 10). We found a comparable rate of 13% of cryptogenic hemoptysis, after performing complete clinical evaluation, chest X-ray, fiberoptic bronchoscopy, and CT scan. The clinical presentation of cryptogenic hemoptysis usually refers to minor and chronic bleeding with a benign course (7) (8) (9) , although recent studies have reported life-threatening cases (3) (4) (5) . Our study suggests that cryptogenic hemoptysis may commonly present as a life-threatening condition, as one-third of our patients had a volume greater than 200 ml on admission, and surgery was needed to control the bleeding in a few of these.
The management of hemoptysis has evolved during the past decade, favoring a least-invasive therapeutic approach (i.e., conservative measures and interventional radiology over emergency surgery). The efficacy and safety of BAE have been established for controlling hemoptysis of various etiologies and severities, both in the short and long term, except for that related to aspergilloma and lung cancer (4, 5, 11-13). However, there is no available information for cryptogenic hemoptysis. In our study, BAE was first attempted in 50 patients (62%) and, when completed, was associated with an immediate control of bleeding in 90% of patients. Altogether, failure of BAE or noncontrol of hemoptysis despite a completed BAE occurred in 11 patients (22%) in whom BAE was first attempted, 6 of whom underwent emergency surgery. Finally, the initial "nonsurgical" approach led to an immediate control of bleeding and to hospital discharge in 73 patients (90%) (Figure 2 ).
There were 10 episodes of recurrence (12%) after discharge, occurring between 1 month and 8 years. No lung cancer occurred during the follow-up. Previous studies have suggested a favorable prognosis for patients with cryptogenic hemoptysis (7-9). Adelman and colleagues (7) reported a spontaneous but more progressive resolution in 67 patients with unexplained minor and chronic hemoptysis, although hemoptysis had resolved completely in only 43% of patients at hospital discharge. In a more recent study of 135 patients with presumed cryptogenic hemoptysis, Herth and colleagues (2) reported that lung cancer was diagnosed in 6% within 3 years after the initial bleeding episode. However, the subset of patients initially studied with CT scan was not specified. Nevertheless, these data suggest that exploration of the underlying lung parenchyma at the time of hemoptysis and during follow-up to exclude small lung carcinoma is warranted. Using multidetector row CT should be helpful in this regard (14) (15) (16) (17) . In our study, no specific lung parenchyma abnormality was evidenced on CT scan, either on initial evaluation or during follow-up, when performed.
The diagnosis of cryptogenic hemoptysis is usually based on the normality of physical examination and endoscopic and radiologic exploration. Our study is the first to provide pathologic findings in this setting. An abnormal superficial vessel contiguous to the epithelium of the bronchial mucosa was demonstrated at pathologic examination of pulmonary resection in more than half of the patients undergoing surgery, mostly in those with high amounts of bleeding. This description corresponds to Dieulafoy's disease of the bronchus, a vascular condition first described in the stomach and regarded as being responsible for 1 to 2% of cases of severe upper gastrointestinal bleeding (18) . Dieulafoy disease of the bronchus has been noted in a few case reports of massive hemoptysis (19) (20) (21) (22) (23) (24) (25) . In our § Failure of arteriography occurred in seven patients, four of whom underwent emergency surgery due to the amount of bleeding (range, 200-600 ml).
§ § Hemoptysis was not controlled in four patients despite a completed bronchial artery embolization, with respective cumulative volumes of 400, 600, 750, and 1,000 ml at the time of embolization. Two of the patients were conservatively managed because of severe comorbid conditions, and subsequently died in hospital. Surgery was performed in the two others. § § § Therapy was withheld in two patients because of severe comorbid conditions (one patient with liver cirrhosis and chronic renal insufficiency; one patient with chronic pulmonary obstructive disease and chronic heart failure). These two patients subsequently died after developing respiratory failure (respective cumulative volumes of 1,000 and 750 ml).
§ § § § One of the two patients who had undergone surgery died postoperatively in a context of hemorrhagic shock due to massive retroperitoneal bleeding. study, the total amount of bleeding (defined as the amount of bleeding on admission plus the subsequent amount of bleeding during hospitalization) was greater than 500 ml in 13 patients (16%), 5 of whom underwent surgery. Dieulafoy disease was demonstrated in four of those five patients who had undergone surgery. None of the preoperative information provided by fi- beroptic bronchoscopy, chest X-ray, or CT scan could have suggested such pathologic findings. The incidence of Dieulafoy disease of the bronchus among patients diagnosed with cryptogenic hemoptysis, after a complete clinical exam and imaging investigations, including CT scan, remains unknown. Our results suggest that this vascular condition may be underestimated among Definition of abbreviations: BAE ϭ bronchial artery embolization; NA ϭ not available. The total volume of initial episode of hemoptysis was calculated as the sum of the volume of bleeding on admission plus the subsequent volume of bleeding during hospitalization. Recurrences were successfully managed with a second-line BAE in two of six patients who had initially been managed conservatively. Bleeding recurred in 3 of 43 patients initially treated by a completed BAE; 2 of them underwent surgery. Conservative ϭ conservative management (see also text).
patients with life-threatening hemoptysis presumed to be cryptogenic. The mechanisms underlying Dieulafoy disease of the bronchus remains unknown. One may hypothesize that chronic bronchial inflammation might participate in the pathogenesis of the disease, as most patients were smokers.
In summary, the clinical spectrum of cryptogenic hemoptysis ranges from a benign to a life-threatening condition. The outcome appears to be rather good, both in the short and long term. A substantial subset of cryptogenic hemoptysis with high amounts of bleeding may reveal a specific bronchial vascular involvement that is not illuminated by the routine methods, including CT scan. Unfortunately, we could not determine any preoperative clinical or radiologic criteria suggesting such pathologic lesions.
